Patent · US Active

Bupropion hydrobromide and therapeutic applications

US8354453B2 · kind B2 · utility

0Cited by
13References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2009
Grant dateJan 15, 2013
Priority date—
Expiry dateSep 26, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of reducing the incidences of bupropion induced seizures by coadministration of a bromide salt with a bupropion salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.